Cargando…
Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India
BACKGROUND: Clinical phenotypes of patients with antibodies to myelin oligodendrocyte glycoprotein (anti-MOG+) are unknown in India. OBJECTIVES: Retrospectively to characterise anti-MOG+ patients with inflammatory central nervous system disorders in India. METHOD: A total of 87 patients with non-mul...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433499/ https://www.ncbi.nlm.nih.gov/pubmed/28607742 http://dx.doi.org/10.1177/2055217316675634 |
_version_ | 1783236869162532864 |
---|---|
author | Pandit, Lekha Sato, Douglas Kazutoshi Mustafa, Sharik Takahashi, Toshiyuki D’Cunha, Anitha Malli, Chaithra Sudhir, Akshatha Fujihara, Kazuo |
author_facet | Pandit, Lekha Sato, Douglas Kazutoshi Mustafa, Sharik Takahashi, Toshiyuki D’Cunha, Anitha Malli, Chaithra Sudhir, Akshatha Fujihara, Kazuo |
author_sort | Pandit, Lekha |
collection | PubMed |
description | BACKGROUND: Clinical phenotypes of patients with antibodies to myelin oligodendrocyte glycoprotein (anti-MOG+) are unknown in India. OBJECTIVES: Retrospectively to characterise anti-MOG+ patients with inflammatory central nervous system disorders in India. METHOD: A total of 87 patients with non-multiple sclerosis demyelinating disorders (excluding acute disseminated encephalomyelitis) who were seronegative for anti-aquaporin 4 antibody were retrospectively analysed using a cell-based assay for anti-MOG+ status. RESULTS: Twenty-five patients were anti-MOG+ in this cohort. They represented 28.7% (25/87) of patients who tested negative for anti-AQP4+. Sixty-four per cent (16/25) of anti-MOG+ patients were men and had a relapsing course. Patients with recurrent optic neuritis and those with a single attack of acute longitudinally extensive transverse myelitis were the most common phenotypes. CONCLUSION: Relapsing optic neuritis was the most common phenotype, contrasting with a lower risk of relapses in transverse myelitis. |
format | Online Article Text |
id | pubmed-5433499 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-54334992017-06-12 Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India Pandit, Lekha Sato, Douglas Kazutoshi Mustafa, Sharik Takahashi, Toshiyuki D’Cunha, Anitha Malli, Chaithra Sudhir, Akshatha Fujihara, Kazuo Mult Scler J Exp Transl Clin Short Report BACKGROUND: Clinical phenotypes of patients with antibodies to myelin oligodendrocyte glycoprotein (anti-MOG+) are unknown in India. OBJECTIVES: Retrospectively to characterise anti-MOG+ patients with inflammatory central nervous system disorders in India. METHOD: A total of 87 patients with non-multiple sclerosis demyelinating disorders (excluding acute disseminated encephalomyelitis) who were seronegative for anti-aquaporin 4 antibody were retrospectively analysed using a cell-based assay for anti-MOG+ status. RESULTS: Twenty-five patients were anti-MOG+ in this cohort. They represented 28.7% (25/87) of patients who tested negative for anti-AQP4+. Sixty-four per cent (16/25) of anti-MOG+ patients were men and had a relapsing course. Patients with recurrent optic neuritis and those with a single attack of acute longitudinally extensive transverse myelitis were the most common phenotypes. CONCLUSION: Relapsing optic neuritis was the most common phenotype, contrasting with a lower risk of relapses in transverse myelitis. SAGE Publications 2016-10-24 /pmc/articles/PMC5433499/ /pubmed/28607742 http://dx.doi.org/10.1177/2055217316675634 Text en © The Author(s) 2016 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Short Report Pandit, Lekha Sato, Douglas Kazutoshi Mustafa, Sharik Takahashi, Toshiyuki D’Cunha, Anitha Malli, Chaithra Sudhir, Akshatha Fujihara, Kazuo Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India |
title | Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India |
title_full | Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India |
title_fullStr | Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India |
title_full_unstemmed | Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India |
title_short | Relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in India |
title_sort | relapsing optic neuritis and isolated transverse myelitis are the predominant clinical phenotypes for patients with antibodies to myelin oligodendrocyte glycoprotein in india |
topic | Short Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5433499/ https://www.ncbi.nlm.nih.gov/pubmed/28607742 http://dx.doi.org/10.1177/2055217316675634 |
work_keys_str_mv | AT panditlekha relapsingopticneuritisandisolatedtransversemyelitisarethepredominantclinicalphenotypesforpatientswithantibodiestomyelinoligodendrocyteglycoproteininindia AT satodouglaskazutoshi relapsingopticneuritisandisolatedtransversemyelitisarethepredominantclinicalphenotypesforpatientswithantibodiestomyelinoligodendrocyteglycoproteininindia AT mustafasharik relapsingopticneuritisandisolatedtransversemyelitisarethepredominantclinicalphenotypesforpatientswithantibodiestomyelinoligodendrocyteglycoproteininindia AT takahashitoshiyuki relapsingopticneuritisandisolatedtransversemyelitisarethepredominantclinicalphenotypesforpatientswithantibodiestomyelinoligodendrocyteglycoproteininindia AT dcunhaanitha relapsingopticneuritisandisolatedtransversemyelitisarethepredominantclinicalphenotypesforpatientswithantibodiestomyelinoligodendrocyteglycoproteininindia AT mallichaithra relapsingopticneuritisandisolatedtransversemyelitisarethepredominantclinicalphenotypesforpatientswithantibodiestomyelinoligodendrocyteglycoproteininindia AT sudhirakshatha relapsingopticneuritisandisolatedtransversemyelitisarethepredominantclinicalphenotypesforpatientswithantibodiestomyelinoligodendrocyteglycoproteininindia AT fujiharakazuo relapsingopticneuritisandisolatedtransversemyelitisarethepredominantclinicalphenotypesforpatientswithantibodiestomyelinoligodendrocyteglycoproteininindia |